Sucampo Pharma to Make Tender Offer For Japan's R-Tech Ueno

Sucampo Pharmaceuticals Inc. agreed to acquire Japan’s R-Tech Ueno Ltd. in a deal valued at about 33 billion yen ($276 million), buying a company controlled by Sucampo’s founders that manufactures all of its drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.